Poland· PL-100381482
Dezaftan med
A sonstige buccale therapeutika product containing cetylpyridinii chloridum + lidocaini hydrochloridum monohydricum + zinci gluconas, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sonstige buccale therapeutika is registered in 7 of 19 countries.
Countries holding a registration under ATC A01AD11 (sonstige buccale therapeutika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Sonstige buccale therapeutika · ATC A01AD11
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Cetylpyridinii chloridum + Lidocaini hydrochloridum monohydricum + Zinci gluconas
- Manufacturer
- Aflofarm Farmacja Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A01AD11
- ATC class
- Sonstige buccale Therapeutika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991403973
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A01AD11
Sonstige buccale therapeutika, as other registers publish it.
- PolandBaxofortAflofarm Farmacja Polska Sp. z o.o.
- PolandCalgelInPharm Sp. z o.o.
- PolandCalgelDelfarma Sp. z o.o.
- CzechiaCALGELMcNeil Healthcare (Ireland) Limited, Dublin
- SwitzerlandCitrokehl, Injektionslösung (i.m.)ebi-pharm ag
- SwitzerlandCitrokehl, Injektionslösung (i.m.)ebi-pharm ag
- SwitzerlandCitrokehl, Injektionslösung (i.m.)ebi-pharm ag
- SwitzerlandDeaftol, solution pour pulvérisation buccaleVerfora SA
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e18cec9d-ef18-4c21-93fd-9326c69788f8 GET /v1/drugs/e18cec9d-ef18-4c21-93fd-9326c69788f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol do stosowania w jamie ustnej, roztwór",
"source": "urpl",
"strength": "(2,9 mg + 1,96 mg + 25,6 mg)/ml",
"packaging": "05909991403973 ¦ OTC ¦ 132056\n1 butelka 30 ml",
"substance": "Cetylpyridinii chloridum 2.94 mg/ml + Lidocaini hydrochloridum monohydricum 1.96 mg/ml + Zinci gluconas 25.6 mg/ml",
"common_name": "Cetylpyridinii chloridum + Lidocaini hydrochloridum monohydricum + Zinci gluconas",
"pl_product_id": "100381482",
"pozwolenie_nr": "25362",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about sonstige buccale therapeutika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.